Satellos group reports 1.14M shares, 7.35% stake
Rhea-AI Filing Summary
Satellos Bioscience Inc. ownership disclosure: three reporting persons state combined beneficial ownership of 1,137,041 ordinary shares, representing 7.35% of the class.
The filing attributes the 7.35% figure to a calculation using 15,458,903 ordinary shares outstanding as of February 5, 2026 and 3,641 common shares issuable upon exercise of options owned by the reporting persons. Ownership breaks down into 126,874 shares with sole voting/dispositive power and 1,010,167 shares with shared voting/dispositive power, held across individuals and affiliated entities named in the filing.
Positive
- None.
Negative
- None.
Insights
Joint holders disclose a meaningful minority stake and shared control.
Bloom/Burton group reports 1,137,041 shares beneficially owned, or 7.35%, calculated using February 5, 2026 outstanding share data. The position combines directly held shares, options, and shares held by affiliated entities.
The filing shows 1,010,167 shares under shared voting/dispositive power via Bloom Burton entities. Future voting alignments or coordinated actions would depend on the reporting persons' joint control arrangements as described; timing and intent are not stated in the excerpt.
Schedule 13G format and percent calculation are explicitly disclosed.
The disclosure cites the issuer's Rule 424(b)(4) Prospectus for the 15,458,903 shares outstanding denominator and includes 3,641 option shares in the calculation. Ownership details enumerate sole vs shared voting and dispositive powers.
There is no transaction or change-of-control statement; this is a beneficial-ownership filing. Any regulatory or Section 13 obligations would follow from the positions reported and applicable rules, not from additional facts in this excerpt.
Key Figures
Key Terms
Beneficially owned regulatory
Rule 424(b)(4) Prospectus regulatory
FAQ
What stake does MSLE reporting group hold?
Who are the reporting persons in the MSLE filing?
How is voting power allocated in the disclosure?
What role do options play in the reported percentage for MSLE?
AI-generated analysis. How Rhea-AI works. Not financial advice.